A5047427435- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Viral-associated cancers and disorders
- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Spine and Intervertebral Disc Pathology
- Pelvic and Acetabular Injuries
- Spinal Fractures and Fixation Techniques
- MRI in cancer diagnosis
Zhejiang Shuren University
2023-2024
First Affiliated Hospital of Zhengzhou University
2023
In this study, we evaluate the effectiveness and safety of conventional transcatheter arterial chemoembolization (C-TACE) drug-loaded microsphere-based TACE (DEB-TACE) in patients with hepatocellular carcinoma (HCC) accompanied by portal vein tumor thrombus (PVTT). A total 51 HCC PVTT treated at our hospital between August 2016 December 2021 were collected retrospectively analyzed. 39 DEB-TACE group 9 C-TACE group, after excluding 3 patients. Serum alpha-fetoprotein (AFP) protein induced...
Vascular invasion is a major risk factor for poor prognosis of liver transplantation (LT) hepatocellular carcinoma (HCC), and this study aimed to evaluate the feasibility efficacy deceased donor LT (DDLT) treatment microvascular (MVI) segmental portal vein tumor thrombus (PVTT).